Back to Man Group plc Man Group plc

IBRXIBRX

Showing 3 of 9 quarters

Position history for Man Group plcMan Group plc's holdings in IMMUNITYBIO INC

No. Man Group exited its IBRX (Immunitybio) position in Q1 2026. Its Q4 2025 13F listed 82,173 shares worth $162,703. Man Group first reported IBRX in Q1 2022 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$249,690

Total Shares Change

-101,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$7.67
0
2025-Q4
Decreased
82,173
-19.0%
$162,7030.0%$1.98
0
2025-Q3
New
101,500
—
$249,6900.0%$2.46
32

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used